Investigators in the phase 3 BENEFIT study evaluated MRD negativity at 12 and 24 months in patients with newly diagnosed multiple myeloma (NDMM) transplant-ineligible (TI) patients.
There is high global demand for critical metals, and many countries want to try extracting these sought-after metals from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback